169 related articles for article (PubMed ID: 9664142)
1. In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid.
Jacob K; Wach F; Holzapfel U; Hein R; Lengyel E; Buettner R; Bosserhoff AK
Melanoma Res; 1998 Jun; 8(3):211-9. PubMed ID: 9664142
[TBL] [Abstract][Full Text] [Related]
2. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.
Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y
J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
4. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2.
Deryugina EI; Luo GX; Reisfeld RA; Bourdon MA; Strongin A
Anticancer Res; 1997; 17(5A):3201-10. PubMed ID: 9413149
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid-enhanced invasion through reconstituted basement membrane by human SK-N-SH neuroblastoma cells involves membrane-associated tissue-type plasminogen activator.
Tiberio A; Farina AR; Tacconelli A; Cappabianca L; Gulino A; Mackay AR
Int J Cancer; 1997 Nov; 73(5):740-8. PubMed ID: 9398056
[TBL] [Abstract][Full Text] [Related]
7. alpha2beta1 integrin signaling via the mitogen activated protein kinase pathway modulates retinoic acid-dependent tumor cell invasion and transcriptional downregulation of matrix metalloproteinase 9 activity.
Vo HP; Lee MK; Crowe DL
Int J Oncol; 1998 Dec; 13(6):1127-34. PubMed ID: 9824620
[TBL] [Abstract][Full Text] [Related]
8. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas.
Airola K; Karonen T; Vaalamo M; Lehti K; Lohi J; Kariniemi AL; Keski-Oja J; Saarialho-Kere UK
Br J Cancer; 1999 May; 80(5-6):733-43. PubMed ID: 10360651
[TBL] [Abstract][Full Text] [Related]
9. Expression and activation of pro-gelatinase A by human melanoma cell lines with different tumorigenic potential.
Capon F; Emonard H; Hornebeck W; Maquart FX; Bernard P
Clin Exp Metastasis; 1999; 17(6):463-9. PubMed ID: 10763911
[TBL] [Abstract][Full Text] [Related]
10. Human breast cancer cells activate procollagenase-1 and invade type I collagen: invasion is inhibited by all-trans retinoic acid.
Benbow U; Schoenermark MP; Orndorff KA; Givan AL; Brinckerhoff CE
Clin Exp Metastasis; 1999 May; 17(3):231-8. PubMed ID: 10432008
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid stimulates meningioma cell adhesion to the extracellular matrix and inhibits invasion.
Pereda MP; Hopfner U; Pagotto U; Renner U; Uhl E; Arzt E; Missale C; Stalla GK
Br J Cancer; 1999 Oct; 81(3):381-6. PubMed ID: 10507760
[TBL] [Abstract][Full Text] [Related]
12. Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis.
Vacca A; Ribatti D; Iurlaro M; Albini A; Minischetti M; Bussolino F; Pellegrino A; Ria R; Rusnati M; Presta M; Vincenti V; Persico MG; Dammacco F
Int J Clin Lab Res; 1998; 28(1):55-68. PubMed ID: 9594364
[TBL] [Abstract][Full Text] [Related]
13. Characterization of selected strongly and weakly invasive sublines of a primary human melanoma cell line and isolation of subtractive cDNA clones.
Jacob K; Bosserhoff AK; Wach F; Knüchel R; Klein EC; Hein R; Buettner R
Int J Cancer; 1995 Mar; 60(5):668-75. PubMed ID: 7532159
[TBL] [Abstract][Full Text] [Related]
14. Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta.
Graham CH; Connelly I; MacDougall JR; Kerbel RS; Stetler-Stevenson WG; Lala PK
Exp Cell Res; 1994 Sep; 214(1):93-9. PubMed ID: 8082752
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
16. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
Ellerbroek SM; Hudson LG; Stack MS
Int J Cancer; 1998 Oct; 78(3):331-7. PubMed ID: 9766568
[TBL] [Abstract][Full Text] [Related]
17. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A
Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137
[TBL] [Abstract][Full Text] [Related]
18. Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis.
Shek FW; Benyon RC; Walker FM; McCrudden PR; Pender SL; Williams EJ; Johnson PA; Johnson CD; Bateman AC; Fine DR; Iredale JP
Am J Pathol; 2002 May; 160(5):1787-98. PubMed ID: 12000730
[TBL] [Abstract][Full Text] [Related]
19. Low-dose retinoic acid enhances in vitro invasiveness of human oral squamous-cell-carcinoma cell lines.
Uchida D; Kawamata H; Nakashiro K; Omotehara F; Hino S; Hoque MO; Begum NM; Yoshida H; Sato M; Fujimori T
Br J Cancer; 2001 Jul; 85(1):122-8. PubMed ID: 11437413
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas.
Kossakowska AE; Edwards DR; Prusinkiewicz C; Zhang MC; Guo D; Urbanski SJ; Grogan T; Marquez LA; Janowska-Wieczorek A
Blood; 1999 Sep; 94(6):2080-9. PubMed ID: 10477738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]